Arun Jangra

Title: Inventor Arun Jangra: Innovating Pharmaceutical Compositions

Introduction

Arun Jangra is a notable inventor based in Kent, GB, recognized for his contributions to the field of pharmaceuticals. With a total of three patents to his name, Jangra has focused on developing innovative methods for producing pharmaceutical compositions that enhance drug efficacy and delivery.

Latest Patents

Among Jangra's latest innovations is the patent for a "Method of producing an extruded composition." This invention outlines a process for creating a direct compression tablet composition that includes ibuprofen, a hydrophilic polymer, and an inorganic excipient. The extrusion process utilized in this method results in a solid dispersion of ibuprofen within the polymer, making it particularly beneficial for preparing oral dissolvable tablets. His second notable patent, "Method of producing a granulated composition," describes a technique for producing an extruded, powdered or granulated composition with an active pharmaceutical ingredient (API). This process allows the API to be at least partially absorbed within the pores of a porous inorganic excipient, enhancing the overall formulation.

Career Highlights

Throughout his career, Arun Jangra has worked with esteemed companies such as Cubic Pharmaceuticals Ltd. and Delta Pharmaceuticals Ltd. His experience in these organizations has contributed significantly to his expertise in pharmaceutical innovations and the development of advanced drug formulations.

Collaborations

In his journey as an inventor, Jangra has collaborated with talented professionals, including Mohammed Maniruzzaman and Saumil Kiritkumar Bhatt. These partnerships have fostered an environment of creativity and collaboration, resulting in impactful advancements in pharmaceutical technology.

Conclusion

Arun Jangra stands out as a dedicated inventor, pushing the boundaries of pharmaceutical development through his innovative methods. With his ongoing commitment to enhancing drug delivery systems, Jangra continues to pave the way for future advancements in the industry. His work not only benefits pharmaceutical companies but also aims to improve patient outcomes significantly.